Specialty Vaccine Company PaxVax, Inc. Selected To Present At Cavendish Global Health Impact Forum

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PaxVax Inc., a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines, today announced that company Chief Executive Officer Ken Kelley will present at the Cavendish Global Health Impact Forum taking place at the United Nations Headquarters and Rockefeller University in New York City, May 5-7, 2014.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC